Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03388372
Recruitment Status : Completed
First Posted : January 3, 2018
Last Update Posted : January 3, 2018
Sun Yat-sen University
Information provided by (Responsible Party):
Shao Xiong Wu, Sun Yat-sen University

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 23, 2017
Actual Study Completion Date : March 23, 2017